Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2023-10-18 Director's Dealing
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Form 8 (DD) - Dechra Pharmaceuticals PLC
Director's Dealing Classification · 99% confidence The document is explicitly titled 'FORM 8 (DD)' and relates to 'PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT' under the 'Takeover Code'. This form details personal share transactions (dealings) by an individual (Ian Page) who is acting in concert with the offeree (Dechra Pharmaceuticals PLC) during an offer period. This directly corresponds to the definition of Director's Dealing (insider trades) or, more specifically in this context, disclosures related to takeover activity involving insider positions. Since the core content is about insider dealings/transactions by a director/concert party member, the most fitting category is 'Director's Dealing' (DIRS). Although it is related to a takeover, the specific action being reported is the change in security holdings by an insider, which aligns best with DIRS, or potentially RNS if DIRS was not available, but DIRS is a specific match for insider transaction reporting.
2023-10-18 English
Form 8 (DD) - Dechra Pharmaceuticals PLC
Director's Dealing Classification · 99% confidence The document is explicitly titled "FORM 8 (DD)" and concerns "PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT" under the "Takeover Code". This type of filing reports personal share transactions by directors or related parties during a takeover scenario. This directly aligns with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades), although this specific form relates to takeover activity. Since there is no specific code for 'Takeover Dealing Disclosure', and it involves executive/insider transactions, DIRS is the closest fit among the provided options, as it captures insider trading activity. It is not a general regulatory announcement (RNS) because it is a highly specific disclosure type (Form 8 DD).
2023-10-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the 'RNS Number : 5720Q' and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds by an entity (UBS Group AG). This type of filing, reporting changes in significant shareholdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this content type.
2023-10-18 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3 - Dechra Pharmaceuticals plc" and contains the header "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" referencing "Rule 8.3 of the Takeover Code (the “Code”)". This form is used to disclose interests and dealings in securities during a takeover offer, which falls under regulatory disclosure related to M&A activity or significant shareholdings during a bid process. While it involves share dealings (related to DIRS or MRQ), the specific context of Rule 8.3 of the Takeover Code strongly suggests it relates to a takeover/merger situation. Given the options, this type of mandatory disclosure during a takeover bid is most closely aligned with M&A Activity (TAR), as it is a direct consequence of a takeover situation involving Dechra Pharmaceuticals plc. It is not a general Director's Dealing (DIRS) as it is mandated by the Takeover Code in the context of an offer, nor is it a Major Shareholding Notification (MRQ) which is broader. Since TAR covers merger proposals or takeover bids, this disclosure is a key component of that process.
2023-10-18 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - Dechra Pharmaceuticals plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder activity during a merger or acquisition process. Among the provided codes, 'TAR' (M&A Activity) is the most appropriate category as it covers merger proposals or takeover bids, which necessitate these specific takeover code filings. The document details positions and dealings related to an offer involving Dechra Pharmaceuticals plc.
2023-10-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the 'RNS Number' and explicitly states it is a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, specifically when a threshold is crossed or reached. This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-10-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.